# Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML

> **NCT02532010** · PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 13 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)

## Interventions

- **DRUG:** Pacritinib
- **DRUG:** Decitabine
- **DRUG:** Cytarabine

## Key facts

- **NCT ID:** NCT02532010
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06-15
- **Primary completion:** 2016-02-09
- **Final completion:** 2017-10-24
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** The study was put on clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints.
- **Last updated:** 2018-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532010, "Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02532010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*